Entering text into the input field will update the search result below

IDEXX Laboratories Q2 revenues up 14%; EPS up 30%; raises EPS guidance

  • IDEXX Laboratories (NASDAQ:IDXX) Q2 results: Revenues: $580.8M (+14.1%); CAG: $507.5M (+15.4%).
  • Net Income: $108.7M (+27.3%); EPS: $1.23 (+29.5%); CF Ops: $153.7M (+8.6%).
  • 2018 Guidance: Revenue: $2,205M - 2,230M from $2,205M - 2,245M; EPS: $4.10 - 4.20 from $4.06 - 4.20.
  • The company achieves 3,241 premium instrument placements, representing 21% Y/Y growth.
  • Shares are down a fraction premarket.

Recommended For You

More Trending News

About IDXX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IDXX--
IDEXX Laboratories, Inc.